Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.81 +0.01 (+1.25%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rani Therapeutics Holdings (RANI) Selling, General & Administrative (2020 - 2026)

Updated

Rani Therapeutics Holdings' Selling, General & Administrative was $5.52 million in Q2 2026, up 10.4% from $5 million a year earlier and up 13.0% from the prior quarter.

Analysis

Rani Therapeutics Holdings (RANI) Selling, General & Administrative (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Rani Therapeutics Holdings' Selling, General & Administrative was $19.53 million through Jun 30, 2026, down 10.0% year-over-year; for FY2025, it came in at $19.74 million, down 17.6% from FY2024.

  • Selling, General & Administrative has now declined for four consecutive years, though with a five-year compound annual growth rate of 31.8% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $23.95 million in FY2024 (-9.6%), $26.48 million in FY2023 (-1.4%), $26.84 million in FY2022 (-3.6%) and $27.83 million in FY2021 (+460.9%).
  • The Q2 2026 figure marks the highest quarterly Selling, General & Administrative since Q1 2025.
  • Compared with a year earlier, Selling, General & Administrative was higher in 1 of the last eight quarters, with an average decline of 11.8%.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q4 2021 (growth of 227.0%); the worst was Q3 2022 (a decline of 54.2%).
  • Per Business Quant data, RANI's Selling, General & Administrative in the three quarters before Q2 2026 was $4.89 million (Q1 2026), $5.09 million (Q4 2025) and $4.04 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Rani Therapeutics Holdings 151.61 Mn 160.36 Mn - 5.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.52 Mn
Mar 31, 2026 4.89 Mn
Dec 31, 2025 5.09 Mn
Sep 30, 2025 4.04 Mn
Jun 30, 2025 5.00 Mn
Mar 31, 2025 5.62 Mn
Dec 31, 2024 5.46 Mn
Sep 30, 2024 5.63 Mn
Jun 30, 2024 6.41 Mn
Mar 31, 2024 6.45 Mn
Dec 31, 2023 5.83 Mn
Sep 30, 2023 6.64 Mn
Jun 30, 2023 7.21 Mn
Mar 31, 2023 6.80 Mn
Dec 31, 2022 7.10 Mn
Sep 30, 2022 7.24 Mn
Jun 30, 2022 6.32 Mn
Mar 31, 2022 6.19 Mn
Dec 31, 2021 5.95 Mn
Sep 30, 2021 15.82 Mn
API Access

Rani Therapeutics Holdings Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RANI&period=max&api_key=YOUR_API_KEY